Joshua D Milner1, Netanya G Sandler, Daniel C Douek. 1. Allergic Inflammation Unit, Laboratory of Allergic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract
PURPOSE OF REVIEW: Patients with hyper IgE syndrome (HIES) share with HIV patients a predisposition to infections, including candidiasis in autosomal dominant HIES (AD-HIES) and molluscum contagiosum and other viral infections in other disorders of elevated IgE with infectious predilections. This review highlights the underlying pathogenesis of these diseases and their relevance to HIV infection. RECENT FINDINGS: Patients with mutations in STAT3, who lack Th17 cells, develop AD-HIES, whereas other disorders of elevated IgE may be caused by mutations in Tyk2 or DOCK8, the latter of which is associated with decreased expansion of CD8 more so than CD4 T cells. Recent studies on patients with recurrent mucocutaneous candidiasis have led to the discovery of mutations in CARD9 and DECTIN-1, genes key to the production of the Th17-driving cytokines IL-1beta, IL-6, and IL-23. Studies of the peripheral blood of HIV-positive patients have shown a decreased Th17:Th1 ratio, and Th17 cells were preferentially depleted from the gastrointestinal tract within weeks of simian immunodeficiency virus infection in rhesus macaques. SUMMARY: The consequences of inadequate Th17 production in primary immunodeficiency syndromes illustrate the role of Th17 cells in controlling pathogens to which HIV-positive individuals are susceptible. Further understanding of the pathogenesis of opportunistic disease in HIV infection will probably require exploring the role of Th17 cells.
PURPOSE OF REVIEW: Patients with hyper IgE syndrome (HIES) share with HIVpatients a predisposition to infections, including candidiasis in autosomal dominant HIES (AD-HIES) and molluscum contagiosum and other viral infections in other disorders of elevated IgE with infectious predilections. This review highlights the underlying pathogenesis of these diseases and their relevance to HIV infection. RECENT FINDINGS:Patients with mutations in STAT3, who lack Th17 cells, develop AD-HIES, whereas other disorders of elevated IgE may be caused by mutations in Tyk2 or DOCK8, the latter of which is associated with decreased expansion of CD8 more so than CD4 T cells. Recent studies on patients with recurrent mucocutaneous candidiasis have led to the discovery of mutations in CARD9 and DECTIN-1, genes key to the production of the Th17-driving cytokines IL-1beta, IL-6, and IL-23. Studies of the peripheral blood of HIV-positive patients have shown a decreased Th17:Th1 ratio, and Th17 cells were preferentially depleted from the gastrointestinal tract within weeks of simian immunodeficiency virus infection in rhesus macaques. SUMMARY: The consequences of inadequate Th17 production in primary immunodeficiency syndromes illustrate the role of Th17 cells in controlling pathogens to which HIV-positive individuals are susceptible. Further understanding of the pathogenesis of opportunistic disease in HIV infection will probably require exploring the role of Th17 cells.
Authors: Alexandra F Freeman; Joie Davis; Victoria L Anderson; William Barson; Dirk N Darnell; Jennifer M Puck; Steven M Holland Journal: Pediatrics Date: 2006-08-28 Impact factor: 7.124
Authors: Erik-Oliver Glocker; Andre Hennigs; Mohammad Nabavi; Alejandro A Schäffer; Cristina Woellner; Ulrich Salzer; Dietmar Pfeifer; Hendrik Veelken; Klaus Warnatz; Fariba Tahami; Sarah Jamal; Annabelle Manguiat; Nima Rezaei; Ali Akbar Amirzargar; Alessandro Plebani; Nicole Hannesschläger; Olaf Gross; Jürgen Ruland; Bodo Grimbacher Journal: N Engl J Med Date: 2009-10-29 Impact factor: 91.245
Authors: Roza I Nurieva; Yeonseok Chung; Daehee Hwang; Xuexian O Yang; Hong Soon Kang; Li Ma; Yi-hong Wang; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong Journal: Immunity Date: 2008-07-03 Impact factor: 31.745
Authors: Elizabeth Melia; Alexandra F Freeman; Yvonne R Shea; Amy P Hsu; Steven M Holland; Kenneth N Olivier Journal: J Allergy Clin Immunol Date: 2009-09 Impact factor: 10.793
Authors: Manish Arora; Preet Bagi; Anna Strongin; Jennifer Heimall; Xiongce Zhao; Monica G Lawrence; Apurva Trivedi; Carolyn Henderson; Amy Hsu; Martha Quezado; David E Kleiner; Aradhana M Venkatesan; Steven M Holland; Alexandra F Freeman; Theo Heller Journal: J Clin Immunol Date: 2017-08-13 Impact factor: 8.317
Authors: Sixto M Leal; Sanhita Roy; Chairut Vareechon; Steven deJesus Carrion; Heather Clark; Manuel S Lopez-Berges; Antonio Di Pietro; Antonio diPietro; Marcus Schrettl; Nicola Beckmann; Bernhard Redl; Hubertus Haas; Eric Pearlman Journal: PLoS Pathog Date: 2013-07-11 Impact factor: 6.823
Authors: Angeline T Dang; Sean Cotton; Sumathi Sankaran-Walters; Chin-Shang Li; Chia-Yuan Michael Lee; Satya Dandekar; Bruce J Paster; Michael D George Journal: BMC Microbiol Date: 2012-07-28 Impact factor: 3.605